Posizolid

Posizolid
Clinical data
ATC code none
Identifiers
Synonyms AZD2563
CAS Number 252260-02-9 YesY
PubChem (CID) 213049
ChemSpider 184741 N
UNII 82V2M8K24R YesY
ECHA InfoCard 100.234.485
Chemical and physical data
Formula C21H21F2N3O7
Molar mass 465.40 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.[1]

References

  1. Wookey, A.; Turner, P. J.; Greenhalgh, J. M.; Eastwood, M.; Clarke, J.; Sefton, C. (2004). "AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro". Clinical Microbiology and Infection. 10 (3): 247–254. doi:10.1111/j.1198-743X.2004.00770.x. PMID 15008947.


This article is issued from Wikipedia - version of the 10/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.